BIORQ
Price
$0.15
Change
+$0.01 (+7.14%)
Updated
Jun 13 closing price
Capitalization
N/A
OCS
Price
$19.02
Change
-$0.66 (-3.35%)
Updated
Jun 13 closing price
Capitalization
970.66M
Interact to see
Advertisement

BIORQ vs OCS

Header iconBIORQ vs OCS Comparison
Open Charts BIORQ vs OCSBanner chart's image
Biora Therapeutics
Price$0.15
Change+$0.01 (+7.14%)
Volume$16.29K
CapitalizationN/A
Oculis Holding AG
Price$19.02
Change-$0.66 (-3.35%)
Volume$71.72K
Capitalization970.66M
BIORQ vs OCS Comparison Chart
Loading...
BIORQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIORQ vs. OCS commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIORQ is a Hold and OCS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (BIORQ: $0.15 vs. OCS: $19.02)
Brand notoriety: BIORQ and OCS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIORQ: 141% vs. OCS: 222%
Market capitalization -- BIORQ: $0 vs. OCS: $970.66M
BIORQ [@Biotechnology] is valued at $0. OCS’s [@Biotechnology] market capitalization is $970.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $356.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIORQ’s FA Score shows that 1 FA rating(s) are green whileOCS’s FA Score has 0 green FA rating(s).

  • BIORQ’s FA Score: 1 green, 4 red.
  • OCS’s FA Score: 0 green, 5 red.
According to our system of comparison, both BIORQ and OCS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIORQ’s TA Score shows that 6 TA indicator(s) are bullish while OCS’s TA Score has 4 bullish TA indicator(s).

  • BIORQ’s TA Score: 6 bullish, 2 bearish.
  • OCS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BIORQ is a better buy in the short-term than OCS.

Price Growth

BIORQ (@Biotechnology) experienced а +4.21% price change this week, while OCS (@Biotechnology) price change was -4.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCS YTD gains are higher at: 11.882 vs. BIORQ (-21.135).
BIORQOCSBIORQ / OCS
CapitalizationN/A971M-
EBITDAN/A-101.78M-
Gain YTD-21.13511.882-178%
P/E RatioN/A63.06-
RevenueN/A0-
Total CashN/A182M-
Total DebtN/A1.1M-
TECHNICAL ANALYSIS
Technical Analysis
BIORQOCS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
36%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
32%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
35%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
48%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
55%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 20 days ago
71%
Declines
ODDS (%)
Bearish Trend 25 days ago
90%
Bearish Trend 5 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
43%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
BIORQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGBHX39.11-0.25
-0.64%
American Funds Global Balanced R5E
GINDX28.52-0.36
-1.25%
Gotham Index Plus Institutional
VDSRX22.53-0.30
-1.31%
Victory Diversified Stock R6
JANVX80.55-1.20
-1.47%
Janus Henderson Venture D
TRSLX4.65-0.08
-1.69%
Transamerica Small Cap Value R

BIORQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIORQ has been closely correlated with HURA. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIORQ jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIORQ
1D Price
Change %
BIORQ100%
+6.50%
HURA - BIORQ
73%
Closely correlated
-6.11%
GNPX - BIORQ
52%
Loosely correlated
-6.77%
SNSE - BIORQ
46%
Loosely correlated
-10.58%
BIVI - BIORQ
34%
Loosely correlated
-4.20%
GRI - BIORQ
33%
Poorly correlated
-7.14%
More

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with HURA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
-3.35%
HURA - OCS
35%
Loosely correlated
-6.11%
CUE - OCS
35%
Loosely correlated
-5.30%
SNSE - OCS
34%
Loosely correlated
-10.58%
BIORQ - OCS
31%
Poorly correlated
+6.50%
CGEN - OCS
28%
Poorly correlated
-1.20%
More